 |
IDEC - Clima e Consumo - Mude o consumo para não mudar o clima
aquecimento global,consumo,mudança climática,hábitos de consumo,calculadora de carbono,tictactictac,efeito estufa,sumidouro de gases,impacto ambiental,sistema de rastreabilidade da carne bovina,meioambiente
Climaeconsumo.org.br ~
Site Info
Whois
Trace Route
RBL Check
|
 |
Gençler Elektronik - Enda, Balluff, Puls Elektronik, LS, LG, LSIS, Datasensor, Tayee, PIL, Sie, Metronix, Fotek, MeanWell, IDEC, Mecapion, Leuze
Gençler Elektronik Otomasyon Ürünleri Satışı ve Elektrik Pano İmalatı
Genclerelektronik.com ~
Site Info
Whois
Trace Route
RBL Check
|
 |
ABB Circuits, Idec Relays, Fuji Switches, Micron Transformers, Optex Sensors, MTE Line Reactors and AEG Motor Control | Morris Automation Group
As a distributor of electrical control components, Morris Automation has in-house stock of the most popular brands and lines, including: ABB circuit breakers, disconnect switces and motor control circuits, idec relays, aeg motor control, micron transformers, optex sensors, mte line reactor, and a full line of Fuji switches and circuit breakers.
Morrisautomation.com ~
Site Info
Whois
Trace Route
RBL Check
|
 |
Rittal | AC Tech | ABB Controls | Carlo Gavazzi | IDEC | Leuze | Hitachi AC Drives | Hammond Manufacturing | Electrical Control Distributors
Electrical control equipment, Rittal, ac tech, abb controls, carlo gavazzi, idec, leuze, hammond manufacturing, Weidmuller, Littelfuse, Hitachi AC Variable Frequency Inverter, Programmable Logic Controllers
Ecdcontrols.com ~
Site Info
Whois
Trace Route
RBL Check
Similar Sites:
electricalcontroldistributors.com
|
 |
RITUXAN® (Rituximab) for Non-Hodgkin’s Lymphoma—RITUXAN® (Rituximab)
Rituxan® (Rituximab), a treatment for certain types of indolent and aggressive non-Hodgkin's lymphoma. This information does not take the place of talking with your doctor. Discuss with your doctor any questions you have about your medical condition or your treatment. Indications and Important Safety Information: RITUXAN® (Rituximab) is indicated for the treatment of patients with: Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent, Previously untreated follicular, CD20-positive, B-cell NHL in combination with CVP chemotherapy, Non-progressing (including stable disease), low-grade, CD20-positive, B-cell NHL, as a single agent, after first-line CVP chemotherapy, Previously untreated diffuse large B-cell, CD20-positive NHL in combination with CHOP or other anthracycline-based chemotherapy regimens. People with serious infections should not receive RITUXAN. Important Safety Information: RITUXAN can cause serious side effects that can lead to death, including: infusion reactions, tumor lysis syndrome (TLS; kidney failure due to fast breakdown of cancer cells), severe skin and mouth reactions, and progressive multifocal leukoencephalopathy (PML; a rare, serious brain infection). RITUXAN has also been associated with serious and life-threatening side effects, including: the return of active hepatitis B virus infection with sudden and serious liver problems including liver failure, and death, other serious infections that can lead to death, heart problems, kidney problems, and stomach and serious bowel problems including blockage and tears in the bowel that can sometimes lead to death. The most common side effects of RITUXAN seen in patients with non-Hodgkin’s lymphoma were infusion reactions, fever, chills, low white blood cells, infections, body aches, and tiredness. Before starting treatment with RITUXAN it is important to talk to your doctor about your medical history.Tell your doctor about any side effect that bothers you or that does not go away. These are not all of the possible side effects with RITUXAN. For more information, ask your doctor. Please see full Prescribing Information, including Medication Guide.
Bcell-lymphoma.com ~
Site Info
Whois
Trace Route
RBL Check
Similar Sites:
facinglymphoma.com
- lymphomaconnection.com
- lymphoma-treatment.com
- non-hodgkins.com
- treat-lymphoma.com
- treat-nhl.com
|
|
|
|
Site Info
